Lab
Long Island Pathology INC
Long Island Pathology INC was paid $306K by Medicaid between May 2020 and Nov 2024, across 45 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 54% of everything it billed.
33Billing provider infoLONG ISLAND PATHOLOGY INC
EAST SETAUKET, NY 11733
EAST SETAUKET, NY 11733
33aNPI1932413002assigned 08/02/2010
33bProvider typeClinical Medical Laboratory
28Total paid$306K
24GClaims9,140
24DCodes billed45
24AFirst – last monthMay 2020 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in New York
Rank by total paid#67 of 116
Median peer was paid$618K
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 314 | $18K | |
| 2021 | 657 | $22K | |
| 2022 | 2,308 | $45K | |
| 2023 | 2,617 | $117K | |
| 2024incomplete | 3,244 | $105K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 54% | 2,328 | 2,215 | $167K |
| 88112 | 12% | 2,548 | 2,501 | $37K | |
| 87506 | 10% | 311 | 309 | $32K | |
| 88342 | 6.3% | 692 | 679 | $19K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.8% | 299 | 221 | $18K |
| 88313 | 3.4% | 449 | 436 | $10K | |
| 88121 | 1.4% | 41 | 41 | $4K | |
| 88312 | 1.2% | 274 | 271 | $4K | |
| 88344 | <1% | 78 | 78 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 17 | 17 | $2K |
| 83993 | <1% | 295 | 293 | $2K | |
| 87505 | <1% | 14 | 14 | $1K |
33 more codes
| 87653 | <1% | 84 | $794.28 | |
| 87563 | <1% | 83 | $785.62 | |
| 87640 | <1% | 83 | $673.76 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 83 | $668.88 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15 | $599.30 |
| 82656 | <1% | 189 | $559.09 | |
| 87338 | <1% | 85 | $398.42 | |
| 83630 | <1% | 111 | $354.91 | |
| 87481 | <1% | 27 | $353.64 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 80 | $266.36 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 72 | $264.11 |
| 82670 | <1% | 79 | $249.28 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 72 | $221.25 |
| 82274 | <1% | 66 | $150.60 | |
| 88304 | <1% | 12 | $140.91 | |
| 82705 | <1% | 41 | $126.62 | |
| 83001 | <1% | 40 | $118.90 | |
| 84702 | <1% | 56 | $90.48 | |
| 80053 | Comprehensive metabolic panel | <1% | 96 | $85.40 |
| 83002 | <1% | 27 | $50.38 | |
| 87209 | <1% | 14 | $47.62 | |
| 84146 | <1% | 14 | $33.34 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 39 | $30.25 |
| 87210 | <1% | 14 | $26.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 44 | $23.71 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 83 | $19.60 |
| 84439 | <1% | 28 | $18.75 | |
| 88142 | <1% | 12 | $14.58 | |
| 85730 | <1% | 29 | $12.49 | |
| 83520 | <1% | 13 | $10.86 | |
| 85610 | <1% | 29 | $8.53 | |
| 86901 | <1% | 43 | $7.31 | |
| 86900 | <1% | 31 | $6.23 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOTHANDARAM, SATHISH (PRESIDENT & CEO)
| Provider | Location | Paid |
|---|---|---|
| Theranostix INC | Beltsville, MD | $5.27M |
| P4 Clinical LLC | Pine Brook, NJ | $964K |
| Platinum Pathology, PLLC | Glen Allen, VA | $216K |
| Excel Medical Lab. INC | Edison, NJ | $150K |
| Theranostix INC | Indianapolis, IN | $8K |
| Metamark Laboratories, INC. | Augusta, GA | $569.11 |
| P4 Diagnostix LLC | Beltsville, MD | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.